Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Junior Gold Miners ETF Market Vectors | GDXJ | 1. avr 2025 | 56.91 | -0.51 |
Juniper Networks | JNPR | 1. avr 2025 | 36.14 | -0.14 |
Jupiter Neurosciences | JUNS | 1. avr 2025 | 0.63 | +2.54 |
JVSPAC Acquisition | JVSAU | 1. avr 2025 | 10.98 | -1.08 |
JVSPAC Acquisition | JVSA | 1. avr 2025 | 10.72 | 0.00 |
JX Luxventure | JXG | 1. avr 2025 | 2.30 | 0.00 |
K&f Growth Acquisition II A | KFII | 1. avr 2025 | 9.97 | 0.00 |
K&F Growth Acquisition II Unit | KFIIU | 1. avr 2025 | 10.09 | 0.00 |
Kadant | KAI | 1. avr 2025 | 343.15 | +1.85 |
Kairos Pharma | KAPA | 1. avr 2025 | 0.92 | -1.73 |
Kaiser Aluminium | KALU | 1. avr 2025 | 59.57 | -1.73 |
Kaival Brands Innovations Group | KAVL | 1. avr 2025 | 0.61 | +10.45 |
Kaixin Holdings | KXIN | 1. avr 2025 | 0.95 | -0.01 |
Kala Bio | KALA | 1. avr 2025 | 5.73 | 0.00 |
Kalaris Therapeutics | KLRS | 1. avr 2025 | 8.00 | 0.00 |
Kaltura | KLTR | 1. avr 2025 | 1.92 | +2.13 |
KalVista Pharmaceuticals | KALV | 1. avr 2025 | 11.15 | -3.34 |
Kamada | KMDA | 1. avr 2025 | 6.70 | +1.36 |
Kandi Technologies Group | KNDI | 1. avr 2025 | 1.37 | -3.52 |
Kanzhun ADR | BZ | 1. avr 2025 | 19.06 | -0.57 |
Karat Packaging | KRT | 1. avr 2025 | 26.70 | +0.45 |
Karman | KRMN | 1. avr 2025 | 33.64 | 0.00 |
Karooooo | KARO | 1. avr 2025 | 41.50 | -2.44 |
Kartoon Studios | TOON | 1. avr 2025 | 0.63 | +2.05 |
Karyopharm Therapeutics | KPTI | 1. avr 2025 | 3.54 | -5.35 |
Katapult | KPLT | 1. avr 2025 | 9.87 | -3.52 |
Kayne Anderson BDC | KBDC | 1. avr 2025 | 16.21 | -0.06 |
Kayne Anderson Energy Infrastructure Fund | KYN | 1. avr 2025 | 12.97 | +1.09 |
Kazia Therapeutics ADR | KZIA | 1. avr 2025 | 0.80 | +1.75 |
KB Financial Group ADR | KB | 1. avr 2025 | 54.64 | +0.98 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.